Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
[This corrects the article DOI: 10.1371/journal.pone.0132546.].
Main Authors: | Gorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, Jacopo Boni, Jordi Serra-Musach, Francesca Mateo, Helena Aguilar, Laia Gómez-Baldó, Anna Petit, August Vidal, Fina Climent, Javier Hernández-Losa, Álex Cordero, Eva González-Suárez, José Vicente Sánchez-Mut, Manel Esteller, Roger Llatjós, Mar Varela, José Ignacio López, Nadia García, Ana I Extremera, Anna Gumà, Raúl Ortega, María Jesús Plà, Adela Fernández, Sònia Pernas, Catalina Falo, Idoia Morilla, Miriam Campos, Miguel Gil, Antonio Román, María Molina-Molina, Piedad Ussetti, Rosalía Laporta, Claudia Valenzuela, Julio Ancochea, Antoni Xaubet, Álvaro Casanova, Miguel Angel Pujana |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6231678?pdf=render |
Similar Items
-
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
by: Gorka Ruiz de Garibay, et al.
Published: (2015-01-01) -
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function
by: Xavier Farré, et al.
Published: (2022-01-01) -
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
by: Carmen Herranz, et al.
Published: (2021-09-01) -
Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
by: Pablo Gámez-Baeza, et al.
Published: (2022-10-01) -
Cellular Biomarkers of Rejection in Lung Transplant: The Usefulness of Eosinophil and Lymphocyte Counts
by: Piedad Ussetti, et al.
Published: (2023-07-01)